Jennifer K. Simpson - Feb 28, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Stock symbol
EGRX
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 05:05 PM
Previous filing
Dec 17, 2021
Next filing
Feb 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EGRX Stock Option (right to buy) Award $0 +11.2K $0.00 11.2K Feb 28, 2022 Common Stock 11.2K $47.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option fully vests on February 28, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.